---
title: Mouse models of pediatric high-grade gliomas with MYCN amplification reveal
  intratumoral heterogeneity and lineage signatures
date: '2023-11-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38001143/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231125170656&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Pediatric high-grade gliomas of the subclass MYCN (HGG-MYCN) are highly
  aggressive tumors frequently carrying MYCN amplifications, TP53 mutations, or both
  alterations. Due to their rarity, such tumors have only recently been identified
  as a distinct entity, and biological as well as clinical characteristics have not
  been addressed specifically. To gain insights into tumorigenesis and molecular profiles
  of these tumors, and to ultimately suggest alternative treatment options, we generated
  ...
disable_comments: true
---
Pediatric high-grade gliomas of the subclass MYCN (HGG-MYCN) are highly aggressive tumors frequently carrying MYCN amplifications, TP53 mutations, or both alterations. Due to their rarity, such tumors have only recently been identified as a distinct entity, and biological as well as clinical characteristics have not been addressed specifically. To gain insights into tumorigenesis and molecular profiles of these tumors, and to ultimately suggest alternative treatment options, we generated ...